Clinical Trials Directory

Trials / Completed

CompletedNCT00952939

Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye

Prognostication of Uveal Melanoma by Fine Needle Aspiration (FNA) and Fluorescence in Situ Hybridization (FlSH)

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Case Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is studying tumor samples in patients undergoing surgery or radiation therapy for primary melanoma of the eye.

Detailed description

OBJECTIVES: Primary * To establish the feasibility of using fine needle aspiration (FNA) and FISH to determine tumor genotype in patients with primary uveal melanoma. Secondary * To characterize ophthalmic complication rate of FNA for FISH analysis in patients undergoing plaque radiotherapy. * To estimate disease-free survival in patients with and without tumor monosomy 3 and/or 8q amplification. * To explore the relationship between tumor monosomy 3 and 8q amplification and plasma levels of tumor immune escape and invasion biomarkers (e.g., circulating granulysin, beta2-microglobulin, autotoxin, lysophosphatidic acid, matrix metalloproteinase-7, tissue inhibitor of matrix metalloproteinase, and soluble E- cadherin). * To explore the psychological impact of prognostication in uveal melanoma. OUTLINE: Patients undergo plaque radiotherapy, enucleation, or tumor resection based upon standard of care guidelines. Trans-scleral fine needle aspiration (FNA) is performed at the time of plaque radiotherapy and ex vivo FNA is performed on enucleation and tumor resection specimens. Tissue samples are analyzed by fluorescence in situ hybridization (FISH). Blood samples are also collected for further analysis. After completion of study therapy, patients are followed up periodically.

Conditions

Interventions

TypeNameDescription
GENETICfluorescence in situ hybridizationAt time of surgery
OTHERlaboratory biomarker analysisAt time of surgery
PROCEDUREfine-needle aspirationAt time of surgery
PROCEDUREtherapeutic conventional surgeryAt time of surgery
OTHERQuestionnairesThe MINI (a structured psychiatric interview) will be administered to all patients that had a pre or post-operative HADS score for suggestive or probable depression or anxiety. A semi-structured interview would be administered to those patients who had some or full decision regret pre-operatively. After completion of the interview, the MINI, a structured psychiatric interview, will be administered.

Timeline

Start date
2009-03-01
Primary completion
2012-09-01
Completion
2014-02-01
First posted
2009-08-06
Last updated
2015-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00952939. Inclusion in this directory is not an endorsement.